23. F. V. Subach et al., Nat. Chem. Biol. 5, 118-126 (2009 in such studies (7) , intensifying the need for alternative models. Here, we report a murine model that recapitulates many features of human infection with hepatitis A virus (HAV), a hepatotropic picornavirus (genus Hepatovirus) that circulates in blood as quasi-enveloped, membrane-cloaked virions and is shed in feces as naked, nonenveloped particles (8) .
Like hepatitis B (HBV) and hepatitis C (HCV) viruses, the host range of HAV is considered restricted to humans and nonhuman primates (2, 9) . However, successful adaptation to growth in murine and guinea pig cells suggests a broader host range (10, 11) . Closely related viruses have also been discovered recently in bats, rodents, shrews, and hedgehogs, with phylogenetic evidence suggesting past shifts among host species (12) . HAV replication is strongly suppressed by type I interferon (IFN) (13) , but HAV-like HCV-blunts IFN responses in human cells by expressing proteinases that degrade MAVS and TRIF, adaptor molecules involved in the induction of IFN (13, 14) . As a result, infected chimpanzees demonstrate limited type I IFN responses (4) . Because the sequences targeted in human MAVS and TRIF are not conserved in small mammals ( fig. S1A ), the inability of HAV to infect these species could stem from a failure to disrupt IFN responses.
To test this hypothesis, we intravenously inoculated Ifnar1
mice, which lack receptors for both type I and type II IFN, with wild-type human HAV (15) . These mice proved highly permissive for infection, developing multiple features of acute hepatitis A in humans (4, 16) : fecal HAV shedding, lowgrade viremia, and elevated serum alanine aminotransferase (ALT) activity (Fig. 1A) . Multifocal inflammatory cell infiltrates, often surrounding necrotic or apoptotic hepatocytes, were present in liver at 37 to 41 days post-inoculation (dpi) together with HAV RNA (Fig. 1B and fig. S2A ). Fecal shedding of infectious virus was confirmed by three subsequent passages in DKO mice, each leading to intrahepatic HAV RNA, fecal virus shedding, and elevated ALT (Fig. 1C and fig. S2B ). inflammatory infiltrates in proximity to cells containing HAV RNA (Fig. 2D and fig. S6B ). The activities of caspases 8 and 9 (and of caspase 3) were slightly increased in infected DKO and Ifnar1 −/− liver ( fig. S6C ), but cleaved caspase was not detected in immunoblots; only~1% of hepatocytes were apoptotic ( fig. S6D ). These data show that apoptosis and inflammation result from a MAVSdependent but IFN-independent mechanism. MAVS-mediated apoptosis has been recognized previously, but its role in vivo is uncertain (19, 20) . Virus was largely restricted to the liver in Mavs −/− mice: HAV genomes were less abundant in spleen by a factor of 400 and were less abundant in lung by three orders of magnitude (Fig.  2E ). Viral RNA was more abundant in spleens of Ifnar1 −/− mice, possibly reflecting sequestration of virus released from damaged hepatocytes.
Little virus was present in ileum or colon of either knockout, indicating that fecal shedding originates in the liver, as in primates (21, 22) . Thus, HAV is highly hepatotropic in mice. Viral shedding persisted unabated for 56 days in Mavs −/− mice with only minimal ALT increases ( Fig. 2F  and fig. S6E ). Rare, isolated apoptotic hepatocytes were observed in only two of five mice at 63 dpi. (Fig. 2A, fig. S5A , and and fig. S8A ). CCL2 (MCP-1) and CCL5 mRNA responses were maximal at 7 dpi, whereas CCL3, IFN-g, and TNF-a mRNAs peaked at 15 dpi (Fig.  3E ) despite the absence of detectable protein in serum or liver. Diminishing chemokine and cytokine responses at 28 dpi (Fig. 3E ) correlated temporally with a decline in fecal virus shedding by two orders of magnitude. NLRP3 inflammasomerelated transcripts were not increased ( fig. S8B ). IFN-b transcription is coordinately regulated by IRF3/7 and nuclear factor (NF)-kB (27) . Phosphorylation of IRF3 confirmed IRF3 activation in infected Ifnar1 −/− mice (Fig. 3F) , and IFN-stimulated genes (ISGs) such as ISG15, IFIT1, and CXCL10 that are directly regulated by IRF3 (28) were induced (Fig. 3 , C, G, and H). IRF3 similarly regulates CCL5 transcription (29), explaining prominent and early CCL5 expression by HAV-infected hepatocytes in Ifnar1 −/− but not Mavs −/− mice (Fig. 3, C and E, and fig. S8C ). The phospho-p65 component of NF-kB was not measurably increased ( fig. S8D ). Several possible mechanisms could account for apoptosis induced through a MAVS-IRF3/7 pathway ( fig. S8E ). First, CCL5 expression could recruit cytotoxic lymphocytes to the liver, resulting in death receptor-mediated apoptosis (30, 31 fig. S11 ). This argues against primary death receptormediated apoptosis. Clodronate depletion of macrophages prior to infection also had no effect on viral replication or inflammation ( fig. S12) .
Alternatively, apoptosis could be induced by ISGs that are directly regulated by IRF3 (28) . The functions of these proteins are only partly understood, but IFIT2 (an ISG that is transcriptionally regulated by IRF3) is known to trigger mitochondrial apoptosis in human cells (28, 32) . IRF3 similarly regulates PMAIP1, a proapoptotic BH3-only protein (33) . Both Ifit2 and Pmaip1 transcripts were induced early, and this induction was more extensive in Ifnar1 −/− mice than in Mavs −/− mice ( fig. S13 ). IRF3 can also induce apoptosis through a transcription-independent mechanism involving a direct interaction with mitochondrial Bax (34) . However, this would not explain the rare apoptotic hepatocytes observed in Irf3-deficient mice ( fig. S7B ).
Although many details remain to be resolved, our data show that Ifnar1 −/− mice provide a useful model that recapitulates many aspects of type A hepatitis in humans. Despite heroic efforts, such a model has proved elusive for HBV or HCV infection (2). Our results suggest that HAV host species range is dictated largely by its capacity to evade MAVS-mediated type I IFN responses, and reveal an unexpected role for MAVS signaling in virus-mediated liver injury. Such signaling leads to IRF3/7-dependent, but IFN-a/b-and IFN-gindependent, hepatocellular apoptosis with a secondary inflammatory response ( fig. S8E ). This may explain why HAV and HCV have evolved independently to target MAVS for degradation. Disrupting innate immune signaling upstream of IRF3/7 not only limits IFN-mediated antiviral responses, but also restricts inflammation within the liver, delays antiviral antibody responses, and slows viral clearance (Fig. 2, D and E, and figs. S3B and S6E). IRF3, activated through STING as a result of endoplasmic reticulum stress, has been implicated recently in acute ethanol-induced hepatitis (35) , suggesting a common final pathway for toxin-and virus-induced liver injury. Our findings establish the critical importance of innate immune responses in control of viral infection in the liver, and provide a paradigm for HAV pathogenesis that is likely relevant to other hepatotropic human viruses. The noncoding genome affects gene regulation and disease, yet we lack tools for rapid identification and manipulation of noncoding elements. We developed a CRISPR screen using~18,000 single guide RNAs targeting >700 kilobases surrounding the genes NF1, NF2, and CUL3, which are involved in BRAF inhibitor resistance in melanoma. We find that noncoding locations that modulate drug resistance also harbor predictive hallmarks of noncoding function. With a subset of regions at the CUL3 locus, we demonstrate that engineered mutations alter transcription factor occupancy and long-range and local epigenetic environments, implicating these sites in gene regulation and chemotherapeutic resistance. Through our expansion of the potential of pooled CRISPR screens, we provide tools for genomic discovery and for elucidating biologically relevant mechanisms of gene regulation.
M ore than 98% of the human genome does not code for proteins; however, unlike for the coding genome, there exists no overarching framework to translate the noncoding genomic sequence into functional elements (1, 2). Evidence from genome-wide association studies suggests that many noncoding regions are critical for human health (3, 4) . The implications of these associations, however, have been difficult to assess, in part because we lack the tools to determine which variants alter functional elements. Molecular hallmarks, such as epigenetic state, chromatin accessibility, transcription factor binding, and evolutionary conservation, correlate with putative functional elements in the noncoding genome and can predict regulatory function (2, 5) . However, these predictions largely bypass regions lacking hallmarks, and it is difficult to ascertain which hallmarks play a correlative or truly causal role in function or phenotype (6, 7). Efforts to determine causality have used preselected DNA fragments, with expression serving as a proxy for function (8) , but these methods lack the local chromatin context and broader regulatory interactions. Thus, there is a need for systematic approaches to sift through noncoding variants and determine whether and how they affect phenotypes in a native biological context.
For this purpose, we designed a high-throughput method that uses pooled CRISPR (clustered regularly interspaced short palindromic repeat)-Cas9 single guide RNA (sgRNA) libraries to screen noncoding genomic loci in order to identify functional regions related to phenotype and gene regulation. Previous applications of CRISPR screens to the noncoding genome have focused on specific functional elements (e.g., microRNAs and transcription factor binding sites) or required fluorescent reporters (9) (10) (11) (12) . In this work, we comprehensively assayed a total of 715 kilobases (kb) of sequence surrounding three different genes by performing unbiased mutagenesis to identify functional elements relevant to cancer drug resistance.
Vemurafenib inhibits BRAF proteins carrying the V600E mutation, which are found in 50 to 70% of melanomas (13) . Resistance to vemurafenib arises within months in almost all melanoma patients (14) , and surviving tumor cells display increased malignancy that rapidly leads to lethality (15) . A genome-scale CRISPR screen found that loss-of-function mutations in NF1, NF2, and CUL3 result in vemurafenib resistance (16) . To explore whether mutations in the noncoding regions around these three genes could similarly affect drug resistance, we designed three sgRNA libraries tiling across 100-kb regions 5′ and 3′ of each gene's major isoforms (Fig. 1A) . For each library, we synthesized the sgRNAs as a pool (6682 for NF1, 6934 for NF2, and 4699 for CUL3; 18,315 sgRNAs in total) and cloned them into a lentiviral vector ( fig. S1 ). We transduced A375 human melanoma cells, which carry the BRAF mutation, with the sgRNA libraries at a low multiplicity of infection and cultured them in 2 uM vemurafenib or control (dimethyl sulfoxide, DMSO) for 14 days. Using deep sequencing, we counted the representation of sgRNAs in both conditions (Fig. 1, B to D) and identified vemurafenibenriched sgRNAs as those enriched by >4 standard deviations from the control distribution ( fig. S2 ).
